Oliver Spandow Power - 14 May 2024 Form 4 Insider Report for NEPHROS INC (NEPH)

Role
Director
Signature
/s/ Christopher Melsha as attorney-in-fact for Oliver Spandow pursuant to power of attorney previously filed.
Issuer symbol
NEPH
Transactions as of
14 May 2024
Net transactions value
$0
Form type
4
Filing time
16 May 2024, 16:25:05 UTC
Previous filing
15 Dec 2023
Next filing
03 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NEPH Common Stock 81,604 14 May 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEPH Stock Option (Right to Buy) Award $0 +7,323 $0.000000 7,323 14 May 2024 Common Stock 7,323 $2.14 Direct F3
holding NEPH Stock Option (Right to Buy) 9,466 14 May 2024 Common Stock 9,466 $5.58 Direct F1
holding NEPH Stock Option (Right to Buy) 5,161 14 May 2024 Common Stock 5,161 $5.85 Direct F1
holding NEPH Stock Option (Right to Buy) 5,568 14 May 2024 Common Stock 5,568 $8.57 Direct F1
holding NEPH Stock Option (Right to Buy) 6,850 14 May 2024 Common Stock 6,850 $8.06 Direct F1
holding NEPH Stock Option (Right to Buy) 7,062 14 May 2024 Common Stock 7,062 $6.82 Direct F1
holding NEPH Stock Option (Right to Buy) 7,080 14 May 2024 Common Stock 7,080 $1.07 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully exercisable.
F2 This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25.
F3 Represents options granted to the reporting person for his service on the Company's Board of Directors for 2023. This option vests as to 2,441 shares on each of 5/14/24, 5/14/25 and 5/14/26.